RC

Rajni Chaudhari

Active Director Director DIN 07647243
DIN 07647243 First appointment Sep 2016 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2016
Shareholding value •••• Premium profile

About Rajni Chaudhari

Data last updated:

Rajni Chaudhari is a Director at Worth Medicines India Private Limited (since 2016). The company operates in Pharma. Worth Medicines India Private Limited reported revenue of ₹7.12 Cr (FY 2024).

DIN 07647243
Primary Designation Director
Industry Pharma
First Appointment 05 Sep 2016
Oldest Company Age 21 yrs
Largest company Worth Medicines India Private Limited · ₹7.12 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director05 Sep 20162005₹7.12 Cr (FY 2024)Active

Board colleagues of Rajni Chaudhari

NameDINCompanyDesignation
Manoj Kumar Chaudhary00813306Worth Medicines India Private LimitedDirector

Directorship timeline

Open interactive timeline →
Worth Medicines India Private Limited
Premium access

Shareholding and investment profile for Rajni Chaudhari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajni Chaudhari

Rajni Chaudhari currently holds 1 directorship: Worth Medicines India Private Limited (Director, since 05 Sep 2016, revenue ₹7.12 Cr (FY 2024)).

Rajni Chaudhari was first appointed on 05 Sep 2016 as Director at Worth Medicines India Private Limited.

The current boards of Rajni Chaudhari's companies include Manoj Kumar Chaudhary (Worth Medicines India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available